Fran Pencliffe of Cambridge Design Partnership explores the benefits of platform devices for parenteral delivery and outlines the challenges, risks and best practices when bringing a combination product to market in this way.
Mark Allen, Andrew Fiorini, and Shai Assia discuss the need to develop delivery devices early when formulating nasally delivered drugs for systemic and local action, and a method by which the route to clinic can be made easier, faster and cheaper.
Senior Consultant Jon Powell shares some of the obstacles encountered conducting pilot builds in-house to help our clients bring devices to market – and gives four pointers for ideal pilot manufacturing for clinical trials.